Gastrointestinal Diseases

Rapid lateral flow immunoassay devices for gastrointestinal diseases. This series covers 10 devices listed in the Notified Body confirmation letter — 10 Class B.

EU regulatory status

165 devices listed in the Notified Body confirmation letter (TÜV Rheinland, NB 0197, 2026-07-10) under Regulation (EU) 2024/1860 — transition to 2028-12-31 (Class C) / 2029-12-31 (Class B).

The confirmation letter records the IVDR application and the signed written agreement, and sets out the transitional arrangements under Regulation (EU) 2024/1860. It is not an IVDR certificate, a CE certificate or an EU Declaration of Conformity, and it does not exempt any device from the remaining conformity assessment steps.

Devices in this series (names as listed in the confirmation letter)

#Device nameBasic UDI-DIIVDR class
1H.Pylori Ab Test Kit697994388Ir03035Class B
2H.Pylori Ag Test Kit697994388Ir03137Class B
3Rotavirus Ag Test Kit697994388Ir0343DClass B
4Adenovirus/Rotavirus Ag Test Panel697994388Ir0353FClass B
5FOB Fecal Occult Blood Test Kit697994388Ir0373KClass B
6TF Transferrin Test Kit697994388Ir0383MClass B
7FOB/TF Test Panel697994388Ir0393PClass B
8Norovirus GI/GII Antigen Detection Kit697994388Ir04038Class B
9Calprotectin (Calp) Detection Kit697994388Ir0413AClass B

Device names are reproduced verbatim from the Notified Body confirmation letter (Table 2). Basic UDI-DIs are the identifiers registered for these devices.

Intended use, performance and specifications

Intended use, sample types, performance characteristics and specifications are as stated in the Instructions for Use (IFU) and the applicable conformity documentation for each device. Device specifications and availability are subject to regulatory approval in each market. No absolute or comparative performance claims are made on this website.

For professional in-vitro diagnostic use only.

Request a quote →